New Delhi, Dec. 25 -- Investors who received an allotment of Anondita Medicare shares appear to be rejoicing, as their IPO bets have turned into massive wealth creation, positioning the stock as one of the biggest wealth creators of 2025 despite heightened market volatility.

The shares hit the secondary market in early September, listing at Rs.275.50 apiece on the NSE SME platform, representing a sharp 90% premium to the issue price of Rs.145. The stellar debut further strengthened momentum, with the stock continuing to hit the 5% upper circuit in subsequent sessions, driving the price up to Rs.867, marking a nearly 500% gain over the IPO price.

An investor who received the minimum retail allotment of two lots, comprising 2,000 shares, ...